FilingReader Intelligence

Fosun Pharma backs subsidiary's growth with guarantee

May 31, 2025 at 05:04 AM UTCBy FilingReader AI

Shanghai Fosun Pharmaceutical Group (Fosun Pharma, SSE:600196) has announced it will provide a guarantee for its subsidiary, Jianjia Medical Investment Management, as it continues to develop its operations. Jianjia Medical will provide a guarantee of up to CNY 11 million for Shanghai Jianjia Rehabilitation Hospital's financing from Bank of Communications. In turn, Jianjia Medical will provide a counter-guarantee by mortgaging some of its own facilities and equipment.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SSE:600196Shanghai Stock Exchange
PharmaceuticalsShanghai Blue Chip

News Alerts

Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →